New evidence
In a meta-analysis of 43 trials, vitamin E was linked to the largest drop in a bone breakdown marker among postmenopausal women — but the finding comes from a single analysis with no specified dose.
This is early evidence from one network meta-analysis, so while it suggests vitamin E may help slow bone loss, it's not yet a settled recommendation — the dose and long-term effects remain unclear.
The study looked at 5,184 postmenopausal women and found that vitamin E reduced CTX, a marker of bone resorption (breakdown), more than other supplements. This could mean vitamin E helps preserve bone density, but because the dose wasn't specified and it's the first such analysis on this pairing, the result should be treated as preliminary.
Where this fits in the evidence
This is among the first studies we've indexed on Vitamin E for Reduced C-terminal Telopeptide Level — treat it as an early signal until more research accumulates.
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.